Esophageal cancer
Conditions
Interventions
Esophageal cancer group:Immunosuppressive therapy
Sponsors
Guang'an People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with stage III-IV esophageal cancer who are inoperable or unwilling to operate; 2. Aged 18 to 80 years, has not received other immune checkpoint inhibition treatment, and is willing to accept immune checkpoint inhibition treatment (consistent with immunosuppressant manufacturers). 3. Gender unlimited; can tolerate relevant treatment; 4. Voluntarily participate in the study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. The patient had multiple distant metastases and the expected survival time was less than 3 months; 2. Combined with other tumors; 3. Patients with other serious chronic diseases such as chronic obstructive pulmonary disease and coronary heart disease affect their survival; 4. Patients who cannot obtain enough blood samples (>= 12 ml); 5. There are anemia, fever, low self immunity, incomplete coagulation function and other conditions that are not suitable for blood drawing; 6. Patients with autoimmune diseases and blood system diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS(progress-free survival); | — |
Secondary
| Measure | Time frame |
|---|---|
| mOS(medium overall survival); | — |
Countries
China
Contacts
Public ContactLong Xiangyu
Guang'an People's Hospital
Outcome results
None listed